AbbVie is reaching for the Sky(rizi) as it spent a staggering $51.5 million on TV drug ads for its immunology blockbuster in October. | AbbVie is reaching for the Sky(rizi) as it spent a staggering ...

Delve into Sanofi's "play to win" strategy as investments are ramping up after their consumer health division's divestment.

Attorneys for the school district say that the legal action is in part due to self-funded insurance plans that has possibly ...

As a wave of patent expirations encroaches upon many of the world’s top drugmakers, companies will need to be diligent in ...

European stocks fell as traders pared back expectations for an interest-rate cut by the Federal Reserve in December after cautious comments from Chair Jerome Powell.

Among Sanofi’s rare disease drugs, new rare blood disorder drug Altuviiio ... Just released: Experts distill 7 elite stocks from the current list of 220 Zacks Rank #1 Strong Buys.

While Sanofi's list price of Aubagio is set at £13,529 ($22,100) per patient a year, NICE was able to recommend it for the NHS after Sanofi made the drug available at a discount under the patient ...

In May, Sanofi set the strictest price increase caps. The company committed not to increase the list price of existing drugs in the US by more than the rate of healthcare inflation and also plans ...

A roundup of the most newsworthy healthcare press releases from PR Newswire this week, including World <a target=_blank ...

The cough and cold relief drugs brand from Procter and Gamble topped the list of Rx and OTC pharma brands by impressions ...

Chicago, IL – October 22, 2024 – Zacks.com announces the list of stocks featured in the ... AbbVie ABBV and Sanofi SNY. Johnson & Johnson’s third-quarter results were strong as it beat ...

The decision makes it impossible to guess what might come next for the healthcare industry. Robert F. Kennedy Jr. is unlike ...